Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients

NCT00558961 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Unsatisfactory enrollment

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Gleevec and Chlorambucil

Sponsor

Jewish General Hospital

Collaborators

[object Object]